Top entities: Phreesia, Kirby McInerney LLP, Balaji Gandhi, Chaim Indig, AccessOne Parent Holdings, Inc..

What category does this event fall under?

Regulatory — classified as securities lawsuit.

What is the sentiment of coverage?

Aggregate sentiment score: -50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

Kirby McInerney LLP filed class action lawsuit Phreesia · Phreesia announced reduced projections · Balaji Gandhi projected revenue

Is this event still developing?

This is an active story, last updated Jun 02, 2026. Coverage continues to evolve.

Regulatory securities lawsuit

Phreesia securities class action filed

Q: When did this event occur?

First reported May 22, 2026; last updated Jun 02, 2026.

Q: What is the market impact?

Direct. The market is negatively impacted by the uncertainty surrounding Phreesia's financial health and the potential for significant legal costs and damages from the lawsuit.

Analysis based on 9 articles · First reported May 22, 2026 · Last updated Jun 02, 2026

Sentiment

-50

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The market is negatively impacted by the uncertainty surrounding Phreesia's financial health and the potential for significant legal costs and damages from the lawsuit. Phreesia's stock price has already seen a substantial decline, reflecting investor concerns about its future revenue and management's transparency.

Healthcare Technology Legal Services

Event Summary

Kirby McInerney LLP has filed a securities class action lawsuit against Phreesia, Inc. on behalf of investors who purchased Phreesia securities between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia made materially false and misleading statements and concealed adverse facts regarding its slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment. Specifically, the company announced significantly reduced revenue growth projections for fiscal year 2027 on March 30, 2026, attributing it to macroeconomic factors and weaker pharmaceutical marketing commitments. This contradicted earlier statements by CFO Balaji Gandhi and CEO Chaim Indig regarding revenue expectations and the benefits of the AccessOne Parent Holdings, Inc. acquisition. Following the announcement, Phreesia's share price declined by approximately 27%. Investors have until July 13, 2026, to seek lead plaintiff appointment in the lawsuit.

Key Actions

100 Kirby McInerney LLP filed class action lawsuit Phreesia

90 Phreesia announced reduced projections

70 Balaji Gandhi projected revenue

70 Chaim Indig stated market expansion

60 Phreesia acquired AccessOne Parent Holdings, Inc.

Entities Involved

stock

Phreesia

Phreesia is the defendant in a securities class action lawsuit, facing allegations of making false and misleading statements regarding its revenue growth projections and business outlook. This event has led to a significant decline in its stock price and potential financial liabilities.

Importance 100 Sentiment -70

priv

Kirby McInerney LLP

Kirby McInerney LLP is the law firm representing investors in the class action lawsuit against Phreesia, actively seeking lead plaintiffs and managing the litigation.

Importance 80 Sentiment 60

per

Balaji Gandhi

Balaji Gandhi, as CFO of Phreesia, made statements regarding fiscal year 2027 revenue projections and the contribution of AccessOne, which are now being scrutinized in the lawsuit.

Importance 50 Sentiment -40

per

Chaim Indig

Chaim Indig, as CEO of Phreesia, made statements about the acquisition of AccessOne and its impact on the addressable market, which are part of the allegations in the lawsuit.

Importance 50 Sentiment -40

priv

AccessOne Parent Holdings, Inc.

AccessOne Parent Holdings, Inc. was acquired by Phreesia, and statements made about its projected revenue contribution and market expansion are relevant to the lawsuit's allegations.

Importance 30 Sentiment 0

exch

New York Stock Exchange

Phreesia's shares are traded on the New York Stock Exchange, where its stock price declined significantly following the announcement of reduced revenue projections.

Importance 10 Sentiment 0

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard